DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will report its financial results for the third quarter of 2012 on Thursday, November 8, 2012 after market close. The announcement of results will be followed by a conference call with the investment community on the same day at 5:00 PM ET.
